Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner
Open Access
- 15 April 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (8) , 1046-1050
- https://doi.org/10.1016/j.amjcard.2004.01.014
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1New England Journal of Medicine, 2003
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsNew England Journal of Medicine, 2003
- Inheritance and Drug ResponseNew England Journal of Medicine, 2003
- Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studyThe Lancet, 2002
- HMG‐CoA reductase inhibitors and P‐glycoprotein modulationBritish Journal of Pharmacology, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- Stimulation of P‐glycoprotein‐mediated drug transport by prazosin and progesteroneEuropean Journal of Biochemistry, 1999
- Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug researchPharmacogenetics, 1998
- Comparison of One-Year Efficacy and Safety of Atorvastatin Versus Lovastatin in Primary HypercholesterolemiaThe American Journal of Cardiology, 1997
- Competitive and Non‐Competitive Inhibition of the Multidrug‐Resistance‐Associated P‐glycoprotein ATPaseEuropean Journal of Biochemistry, 1997